228 search results for: Burden of Disease

The Path to Nodules: Type 2 Inflammation at the Core <b>of</b> Chronic Itch and Fibrosis in Prurigo Nodularis
Type 2 Inflammation
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
expert video

Join Dr. Shawn Kwatra in discussing the diverse clinical presentations of PN and the role of type 2 inflammation in disease pathogenesis.

View more
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Dermatology
Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
expert video

Watch Drs. Simpson and Armstrong explore the clinical presentations, diagnostic challenges, and significant burdens experienced by patients with atopic dermatitis and hand and foot dermatitis, as well as the role type 2 inflammation plays in both of these diseases.

View more
Importance <b>of</b> Assessing Key <b>Disease</b> Domains in EoE Infographic
Gastroenterology
Importance of Assessing Key Disease Domains in EoE Infographic
Infographic

Learn about the importance of assessing key disease domains in EoE by focusing on symptoms, QoL, endoscopy, and histology.

View more
Eosinophils as a Biomarker for Type 2 Asthma
Pulmonology
Eosinophils as a Biomarker for Type 2 Asthma
expert video

Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.

View more
FeNO as a Biomarker for Type 2 Asthma
Pulmonology
FeNO as a Biomarker for Type 2 Asthma
expert video

Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation and its role in the disease burden of asthma.

View more
ERS 2024 | Living With COPD: Linking Inflammation with Patient <b>Burden</b>
Pulmonology
ERS 2024 | Living With COPD: Linking Inflammation with Patient Burden
expert video

Professor Henrik Watz explores the complex relationship between inflammation and COPD, highlighting its impact on patients' health and overall quality of life.

View more
Understanding the Full Scope <b>of</b> PN: Lesions, Dyspigmentation, and Patient <b>Burden</b>
Dermatology
Understanding the Full Scope of PN: Lesions, Dyspigmentation, and Patient Burden
expert video

Professor Matthias Augustin details the various clinical manifestations of prurigo nodularis, illustrating how different lesion types can present concurrently in patients.

View more
AANP 2025 | Atopic <b>Disease</b>s & a Case-Based Panel <b>of</b> Nurse Practitioners
Type 2 Inflammation
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

View more
Importance <b>of</b> Assessing Multiple <b>Disease</b> Domains in EoE
Gastroenterology
Importance of Assessing Multiple Disease Domains in EoE
expert video

Prof. Arjan Bredenoord and Dr. Evan Dellon emphasize the need to assess multiple disease domains to get the complete picture of patients’ EoE.

View more
Understanding IL-33: A Key Factor in COPD Pathogenesis
Pulmonology
Understanding IL-33: A Key Factor in COPD Pathogenesis
interactivity

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

View more
The <b>Burden</b> <b>of</b> Chronic Spontaneous Urticaria:  One Patient’s Journey to Diagnosis
Dermatology
The Burden of Chronic Spontaneous Urticaria: One Patient’s Journey to Diagnosis
videoanimation

Learn about the clinical presentation of CSU and the burden many CSU patients face by following one patient’s journey from symptom presentation to CSU diagnosis in this 5-minute video.

View more
ADVENT at ERS 2024
On Demand
ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz and Mona Bafadhel for an educational symposium exploring the role of type 2 cytokines in COPD and delve into the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden.